Analytical interference of HBOC-201 (Hemopure, a synthetic hemoglobin-based oxygen carrier) on four common clinical chemistry platforms

Add time:09/01/2019    Source:sciencedirect.com

BackgroundThere are 13 million blood transfusions each year in the US. Limitations in the donor pool, storage capabilities, mass casualties, access in remote locations and reactivity of donors all limit the availability of transfusable blood products to patients. HBOC-201 (Hemopure®) is a second-generation glutaraldehyde-polymer of bovine hemoglobin, which can serve as an “oxygen bridge” to maintain oxygen carrying capacity while transfusion products are unavailable. Hemopure presents the advantages of extended shelf life, ambient storage, and limited reactive potential, but its extracellular location can also cause significant interference in modern laboratory analyzers similar to severe hemolysis.

We also recommend Trading Suppliers and Manufacturers of hemoglobin Nevers (cas 132822-83-4). Pls Click Website Link as below: cas 132822-83-4 suppliers

Prev:Original articleAdult cardiacHemoglobin Optimization for Coronary Bypass: A 10-Year Canadian Multicenter Experience
Next:Hemoglobin A1C is independently associated with severity and prognosis of brainstem infarctions)